Breaking News Instant updates and real-time market news.

RDHL

RedHill Biopharma

$6.77 /

+0.085 (+1.27%)

07:51
05/05/20
05/05
07:51
05/05/20
07:51

RedHill Biopharma announces publication of results of Phase 3 study of Talicia

RedHill Biopharma announced the publication of the Company's pivotal Phase 3 study results with Talicia for Helicobacter pylori infection in the Annals of Internal Medicine. The peer-reviewed article, entitled "Rifabutin-Based Triple Therapy for Helicobacter pylori Eradication: A Double-Blind, Randomized, Controlled Trial", is available online and the print article is scheduled to be published in the journal's June issue. Talicia was approved by the FDA in November 2019. It is the only rifabutin-containing therapy approved for the treatment of H. pylori infection and is designed to address the high and growing resistance of H. pylori to the currently widely used clarithromycin-containing regimens. The double-blind, randomized, controlled trial compared Talicia against an equivalent dose dual therapy of amoxicillin and omeprazole in 455 treatment-naive subjects with confirmed dyspepsia and H. pylori infection. Results demonstrated the added rifabutin benefit with 83.8% eradication of H. pylori infection with Talicia vs. 57.7% in the active comparator arm, showing a 26.1% benefit with Talicia. The subjects who were confirmed adherent to their therapy had response rates of 90.3% in the Talicia arm vs. 64.7% in the active comparator arm. No resistance to rifabutin, a key component of Talicia, was detected in the study. Efficacy was not reduced by the presence of clarithromycin or metronidazole resistance, which were noted to be 17.4% and 43.6%, respectively. Furthermore, the safety profiles of both Talicia and the active comparator were similar. These findings support the potential for Talicia as a preferred first-line empirical H. pylori therapy, addressing an unmet need in the current environment of increasing antibiotic resistance. In addition, an ePoster entitled "Pharmacokinetics and Exposure-Response of RHB-105, A Novel Fixed-Dosed Rifabutin-Based Combination Treatment of Helicobacter Pylori", was published online on May 3, 2020 as part of Digestive Disease Week 2020 online education portal, following the cancellation of this year's conference. The ePoster and accompanying presentation describe key findings from the pharmacokinetic analysis of the pivotal Phase 3 study with Talicia. The authors conclude that the curative effect of Talicia is sensitive to the exposure of rifabutin, further supporting the clinical results of the study and superiority over the dual therapy.

RDHL RedHill Biopharma
$6.77 /

+0.085 (+1.27%)

02/27/20 Roth Capital
RedHill Biopharma price target lowered to $15 from $20.25 at Roth Capital
07/12/19 WBB Securities
RedHill Biopharma upgraded to Strong Buy from Buy at WBB Securities

TODAY'S FREE FLY STORIES

Hot Stocks
Robotics firm Nuro Partners with CVS on autonomous prescription deliveries » 11:47
05/28/20
05/28
11:47
05/28/20
11:47
CVS

CVS Health

$67.43 /

+1.46 (+2.21%)

In a recent blog post on…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CVS CVS Health
$67.43 /

+1.46 (+2.21%)

CVS CVS Health
$67.43 /

+1.46 (+2.21%)

05/14/20
Fly Intel: Top five analyst upgrades
05/14/20 Credit Suisse
CVS upgraded to Outperform on 'compelling' valuation at Credit Suisse
05/14/20 Credit Suisse
CVS Health upgraded to Outperform from Neutral at Credit Suisse
03/25/20 RBC Capital
CVS Health price target lowered to $81 from $85 at RBC Capital
CVS CVS Health
$67.43 /

+1.46 (+2.21%)

CVS CVS Health
$67.43 /

+1.46 (+2.21%)

CVS CVS Health
$67.43 /

+1.46 (+2.21%)

CVS CVS Health
$67.43 /

+1.46 (+2.21%)

Recommendations
GEA Group price target raised to EUR 22 from EUR 21 at Credit Suisse » 11:46
05/28/20
05/28
11:46
05/28/20
11:46
GEAGY

GEA Group

$0.00 /

+ (+0.00%)

Credit Suisse analyst Max…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GEAGY GEA Group
$0.00 /

+ (+0.00%)

05/27/20 Deutsche Bank
GEA Group price target raised to EUR 19 from EUR 15 at Deutsche Bank
05/19/20 UBS
GEA Group price target lowered to EUR 27 from EUR 29 at UBS
05/19/20 JPMorgan
GEA Group price target raised to EUR 18.50 from EUR 16 at JPMorgan
05/18/20 Morgan Stanley
GEA Group price target raised to EUR 24 from EUR 22 at Morgan Stanley
Hot Stocks
Amazon offering 120,000 full-time jobs to seasonal employees » 11:46
05/28/20
05/28
11:46
05/28/20
11:46
AMZN

Amazon.com

$2,415.00 /

+4 (+0.17%)

Amazon said in a blog…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AMZN Amazon.com
$2,415.00 /

+4 (+0.17%)

AMZN Amazon.com
$2,415.00 /

+4 (+0.17%)

05/27/20 Morgan Stanley
Amazon deal could open door for ridesharing competition, says Morgan Stanley
05/18/20 Bernstein
Amazon not building standalone overnight network, says Bernstein
05/14/20 KeyBanc
Farfetch, Nordstrom, Revolve could be impacted by Amazon offering, says KeyBanc
05/12/20 Barrington
Amazon interest in AMC 'not outside the realm of possibility,' says Barrington
AMZN Amazon.com
$2,415.00 /

+4 (+0.17%)

AMZN Amazon.com
$2,415.00 /

+4 (+0.17%)

AMZN Amazon.com
$2,415.00 /

+4 (+0.17%)

AMZN Amazon.com
$2,415.00 /

+4 (+0.17%)

AMZN Amazon.com
$2,415.00 /

+4 (+0.17%)

Conference/Events
Cantor Fitzgerald healthcare analysts to hold analyst/industry conference call » 11:46
05/28/20
05/28
11:46
05/28/20
11:46

Healthcare Analysts…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

General news
8-Week Bill Auction Total Amount data reported » 11:44
05/28/20
05/28
11:44
05/28/20
11:44

8-Week Bill Auction Total…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

General news
4-Week Bill Auction Total Amount data reported » 11:44
05/28/20
05/28
11:44
05/28/20
11:44

4-Week Bill Auction Total…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Hot Stocks
Toll Brothers focused on growth in mountain states, South  11:44
05/28/20
05/28
11:44
05/28/20
11:44
TOL

Toll Brothers

$33.63 /

+0.685 (+2.08%)

 
ShowHide Related Items >><<
TOL Toll Brothers
$33.63 /

+0.685 (+2.08%)

TOL Toll Brothers
$33.63 /

+0.685 (+2.08%)

05/27/20 Credit Suisse
Toll Brothers initiated with a Neutral at Credit Suisse
05/27/20 Credit Suisse
KB Home initiated with an Outperform at Credit Suisse
05/11/20 Wedbush
Toll Brothers price target lowered to $35 from $48 at Wedbush
05/04/20 Evercore ISI
Toll Brothers upgraded to In Line from Underperform at Evercore ISI
TOL Toll Brothers
$33.63 /

+0.685 (+2.08%)

TOL Toll Brothers
$33.63 /

+0.685 (+2.08%)

TOL Toll Brothers
$33.63 /

+0.685 (+2.08%)

On The Fly
Alexion rises as documents suggest settlement of Amgen patent challenge » 11:41
05/28/20
05/28
11:41
05/28/20
11:41
ALXN

Alexion

$115.45 /

+9.28 (+8.74%)

, AMGN

Amgen

$224.79 /

-0.02 (-0.01%)

, SNY

Sanofi

$48.89 /

+1.38 (+2.90%)

, REGN

Regeneron

$566.53 /

+22.52 (+4.14%)

Shares of Alexion (ALXN)…

Open Full Text

ShowHide Related Items >><<
ALXN Alexion
$115.45 /

+9.28 (+8.74%)

AMGN Amgen
$224.79 /

-0.02 (-0.01%)

SNY Sanofi
$48.89 /

+1.38 (+2.90%)

REGN Regeneron
$566.53 /

+22.52 (+4.14%)

ALXN Alexion
$115.45 /

+9.28 (+8.74%)

09:08 Today Piper Sandler
Alexion settlement could 'clear the deck' for acquirer, says Piper Sandler
08:48 Today Cowen
Alexion settlement may yield upside surprise, says Cowen
07:59 Today Stifel
Alexion, Amgen appear to have agreed to settlement deal, says Stifel
05/26/20 BMO Capital
BMO Capital still sees favorable risk/reward in Alexion following Argenx news
AMGN Amgen
$224.79 /

-0.02 (-0.01%)

09:08 Today Piper Sandler
Alexion settlement could 'clear the deck' for acquirer, says Piper Sandler
08:48 Today Cowen
Alexion settlement may yield upside surprise, says Cowen
07:59 Today Stifel
Alexion, Amgen appear to have agreed to settlement deal, says Stifel
05/22/20 Piper Sandler
Harpoon Therapeutics initiated with an Overweight at Piper Sandler
SNY Sanofi
$48.89 /

+1.38 (+2.90%)

09:08 Today Piper Sandler
Alexion settlement could 'clear the deck' for acquirer, says Piper Sandler
05/27/20 Citi
BioMarin a good takeout candidate, but not by Sanofi, says Citi
05/26/20 UBS
Sanofi price target lowered to EUR 101 from EUR 103 at UBS
05/26/20 Piper Sandler
Piper remains buyer of Regeneron, ups target to $630 on buyback accretion
REGN Regeneron
$566.53 /

+22.52 (+4.14%)

09:08 Today Piper Sandler
Alexion settlement could 'clear the deck' for acquirer, says Piper Sandler
06:47 Today Barclays
Regeneron price target raised to $615 from $530 at Barclays
05/27/20 Citi
BioMarin a good takeout candidate, but not by Sanofi, says Citi
05/26/20
Fly Intel: Top five analyst upgrades
ALXN Alexion
$115.45 /

+9.28 (+8.74%)

AMGN Amgen
$224.79 /

-0.02 (-0.01%)

SNY Sanofi
$48.89 /

+1.38 (+2.90%)

REGN Regeneron
$566.53 /

+22.52 (+4.14%)

  • 27
    May
ALXN Alexion
$115.45 /

+9.28 (+8.74%)

AMGN Amgen
$224.79 /

-0.02 (-0.01%)

SNY Sanofi
$48.89 /

+1.38 (+2.90%)

REGN Regeneron
$566.53 /

+22.52 (+4.14%)

ALXN Alexion
$115.45 /

+9.28 (+8.74%)

AMGN Amgen
$224.79 /

-0.02 (-0.01%)

SNY Sanofi
$48.89 /

+1.38 (+2.90%)

REGN Regeneron
$566.53 /

+22.52 (+4.14%)

ALXN Alexion
$115.45 /

+9.28 (+8.74%)

SNY Sanofi
$48.89 /

+1.38 (+2.90%)

REGN Regeneron
$566.53 /

+22.52 (+4.14%)

Options
Put spread purchase in High Yield Bond ETF likely closes » 11:40
05/28/20
05/28
11:40
05/28/20
11:40
HYG

iShares iBoxx $ High Yield Corporate Bond

$82.17 /

+0.16 (+0.20%)

Put spread purchase in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HYG iShares iBoxx $ High Yield Corporate Bond
$82.17 /

+0.16 (+0.20%)

HYG iShares iBoxx $ High Yield Corporate Bond
$82.17 /

+0.16 (+0.20%)

HYG iShares iBoxx $ High Yield Corporate Bond
$82.17 /

+0.16 (+0.20%)

Options
Royal Dutch Shell put volume heavy and directionally bearish » 11:35
05/28/20
05/28
11:35
05/28/20
11:35

Bearish flow noted in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

General news
Energy Action: The weekly EIA inventory data » 11:35
05/28/20
05/28
11:35
05/28/20
11:35

Energy Action: The weekly…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Hot Stocks
Driver Management calls ISS report on First United Corp 'flawed' » 11:34
05/28/20
05/28
11:34
05/28/20
11:34
FUNC

First United Corp

$14.70 /

+ (+0.00%)

Driver Management…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FUNC First United Corp
$14.70 /

+ (+0.00%)

Hot Stocks
Aurora Cannabis completes acquisition of Reliva for approximately $40M in stock » 11:34
05/28/20
05/28
11:34
05/28/20
11:34
ACB

Aurora Cannabis

$16.50 /

+1.24 (+8.13%)

Aurora Cannabis announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ACB Aurora Cannabis
$16.50 /

+1.24 (+8.13%)

ACB Aurora Cannabis
$16.50 /

+1.24 (+8.13%)

05/22/20 CIBC
Aurora Cannabis price target raised to C$24 from C$14 at CIBC
05/22/20
Fly Intel: Top five analyst downgrades
05/22/20 Jefferies
Aurora Cannabis downgraded to Underperform from Hold at Jefferies
05/21/20 Stifel
Stifel keeps Sell rating on Aurora, calls Reliva deal a 'small but good step'
ACB Aurora Cannabis
$16.50 /

+1.24 (+8.13%)

ACB Aurora Cannabis
$16.50 /

+1.24 (+8.13%)

ACB Aurora Cannabis
$16.50 /

+1.24 (+8.13%)

ACB Aurora Cannabis
$16.50 /

+1.24 (+8.13%)

Earnings
Fly Intel: What to watch in Salesforce earnings report » 11:33
05/28/20
05/28
11:33
05/28/20
11:33
CRM

Salesforce

$182.18 /

+5.61 (+3.18%)

, RTW

RTW Retailwinds

$0.44 /

-0.0174 (-3.80%)

, BBW

Build-A-Bear

$2.25 /

+0.04 (+1.81%)

Salesforce (CRM) is…

Salesforce (CRM) is scheduled to report results of its first fiscal quarter after the market close on Thursday, May 28, with a conference call scheduled for 5:00 pm ET. What to watch for: 1. GUIDANCE: Along with its fourth quarter earnings report, Salesforce set its fiscal year 2021 adjusted earnings per share view at $3.16-$3.18. Consensus for earnings, which was $3.10 at the time, has remained the same. The company also raised its 2021 revenue view to $21B-$21.1B from $20.8B-$20.9B. Consensus, which was $20.93B at the time, has dropped slightly to $20.77B. In addition, the company provided first quarter adjusted EPS guidance of 70c-71c on a revenue of $4.875B-$4.885B. Consensus for earnings, which was at 55c at the time, has risen to 69c, and estimates for revenue, which was at $4.84B, have increased to $4.85B. 2. CO-CEO STEPS DOWN: The company announced in February that Keith Block had stepped down as co-CEO of Salesforce and Marc Benioff would remain as Chair and CEO of the company. Additionally, Salesforce named Gavin Patterson, former BT Group CEO, its president and CEO of Salesforce International. 3. VLOCITY ACQUISITION: The company announced with its earnings report that it entered into an agreement to acquire Vlocity, a provider of industry-specific cloud and mobile software built natively on the Salesforce platform, for approximately $1.33B. The purchase price will be paid in cash and the assumption of outstanding unvested equity awards held by Vlocity employees. The acquisition is expected to close during Q2 of 2021, subject to customary closing conditions. 4. PARTNERSHIPS: RTW Retailwinds (RTW) announced in February a multi-year partnership for Salesforce to be its new digital ecommerce platform partner for all businesses, including New York & Company, Fashion to Figure, and Happy x Nature. Additionally in March, Salesforce announced an expanded relationship with Build-A-Bear Workshop (BBW) as its strategic partner in digital transformation. 5. ANALYST VIEWS: In May, Oppenheimer analyst Brian Schwartz raised the firm's price target on Salesforce to $195 from $165 and kept an Outperform rating on the shares. While the analyst acknowledges that the company is not immune from the COVID-19 issues, he believes the high priority SaaS enjoys across global enterprises is broadly unchanged. Jefferies analyst Brent Thill also raised the firm's price target on Salesforce to $205 from $180 and kept a Buy rating on the shares. The analyst noted that his survey of over 50 partners indicated that over 70% saw their CRM pipelines decrease due to the pandemic, but longer term, he sees its pipeline remaining robust. Additionally in May, RBC Capital analyst Alex Zukin lowered the firm's price target on Salesforce to $210 from $230 but kept an Outperform rating on the shares. The analyst said the company is not immune to the global demand trends, but he continues to see its Service Cloud, Commerce Cloud, Healthcare, FinServ and Contact Tracing efforts driving bookings momentum.

ShowHide Related Items >><<
CRM Salesforce
$182.18 /

+5.61 (+3.18%)

RTW RTW Retailwinds
$0.44 /

-0.0174 (-3.80%)

BBW Build-A-Bear
$2.25 /

+0.04 (+1.81%)

CRM Salesforce
$182.18 /

+5.61 (+3.18%)

09:06 Today Needham
Workday price target raised to $200 from $175 at Needham
05/18/20 Jefferies
Salesforce price target raised to $205 from $180 at Jefferies
05/18/20 RBC Capital
Salesforce price target lowered to $210 from $230 at RBC Capital
05/18/20 Cowen
Salesforce price target lowered to $200 from $220 at Cowen
RTW RTW Retailwinds
$0.44 /

-0.0174 (-3.80%)

BBW Build-A-Bear
$2.25 /

+0.04 (+1.81%)

12/13/19 Jefferies
Removal, delay of China tariffs give 'reprieve' to toy companies, says Jefferies
CRM Salesforce
$182.18 /

+5.61 (+3.18%)

BBW Build-A-Bear
$2.25 /

+0.04 (+1.81%)

CRM Salesforce
$182.18 /

+5.61 (+3.18%)

CRM Salesforce
$182.18 /

+5.61 (+3.18%)

BBW Build-A-Bear
$2.25 /

+0.04 (+1.81%)

CRM Salesforce
$182.18 /

+5.61 (+3.18%)

Hot Stocks
Toll Brothers saw highest deposit number since 2005 last week  11:26
05/28/20
05/28
11:26
05/28/20
11:26
TOL

Toll Brothers

$33.97 /

+1.025 (+3.11%)

 
ShowHide Related Items >><<
TOL Toll Brothers
$33.97 /

+1.025 (+3.11%)

TOL Toll Brothers
$33.97 /

+1.025 (+3.11%)

05/27/20 Credit Suisse
Toll Brothers initiated with a Neutral at Credit Suisse
05/27/20 Credit Suisse
KB Home initiated with an Outperform at Credit Suisse
05/11/20 Wedbush
Toll Brothers price target lowered to $35 from $48 at Wedbush
05/04/20 Evercore ISI
Toll Brothers upgraded to In Line from Underperform at Evercore ISI
TOL Toll Brothers
$33.97 /

+1.025 (+3.11%)

TOL Toll Brothers
$33.97 /

+1.025 (+3.11%)

TOL Toll Brothers
$33.97 /

+1.025 (+3.11%)

Recommendations
Royal Bank of Canada price target raised to C$105 from C$97 at Scotiabank » 11:25
05/28/20
05/28
11:25
05/28/20
11:25
RY

Royal Bank of Canada

$66.17 /

-0.81 (-1.21%)

Scotiabank analyst Sumit…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RY Royal Bank of Canada
$66.17 /

-0.81 (-1.21%)

RY Royal Bank of Canada
$66.17 /

-0.81 (-1.21%)

10:43 Today Canaccord
Royal Bank of Canada price target raised to C$95 from C$86.50 at Canaccord
05/22/20 Scotiabank
Royal Bank of Canada price target lowered to C$97 from C$99 at Scotiabank
05/06/20 Citi
Royal Bank of Canada upgraded to Buy from Neutral at Citi
05/06/20 Citi
Royal Bank of Canada upgraded to Buy from Neutral at Citi
RY Royal Bank of Canada
$66.17 /

-0.81 (-1.21%)

RY Royal Bank of Canada
$66.17 /

-0.81 (-1.21%)

Options
Chewy call volume above normal and directionally bullish » 11:25
05/28/20
05/28
11:25
05/28/20
11:25
CHWY

Chewy

$41.95 /

+1.83 (+4.56%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CHWY Chewy
$41.95 /

+1.83 (+4.56%)

CHWY Chewy
$41.95 /

+1.83 (+4.56%)

04/20/20
Chewy cut to Neutral at UBS on longer term headwinds
04/20/20 UBS
Chewy downgraded to Neutral from Buy at UBS
04/17/20 Morgan Stanley
Chewy downgraded to Equal Weight following outperformance at Morgan Stanley
04/17/20 Credit Suisse
Chewy price target raised to $46 from $37 at Credit Suisse
CHWY Chewy
$41.95 /

+1.83 (+4.56%)

CHWY Chewy
$41.95 /

+1.83 (+4.56%)

CHWY Chewy
$41.95 /

+1.83 (+4.56%)

CHWY Chewy
$41.95 /

+1.83 (+4.56%)

General news
Treasury announced a $117 B package of 3- and 6-month bill auctions for Monday » 11:25
05/28/20
05/28
11:25
05/28/20
11:25

Treasury announced a $117…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Conference/Events
Varonis participates in a conference call with JMP Securities » 11:25
05/28/20
05/28
11:25
05/28/20
11:25
VRNS

Varonis

$85.00 /

+1.89 (+2.27%)

Cybersecurity & IT…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VRNS Varonis
$85.00 /

+1.89 (+2.27%)

VRNS Varonis
$85.00 /

+1.89 (+2.27%)

05/05/20 DA Davidson
Varonis price target raised to $85 from $65 at DA Davidson
05/05/20 Craig-Hallum
Varonis downgraded to Hold at Craig-Hallum
05/05/20 Wedbush
Varonis price target lowered to $88 from $105 at Wedbush
05/05/20 Craig-Hallum
Varonis downgraded to Hold from Buy at Craig-Hallum
VRNS Varonis
$85.00 /

+1.89 (+2.27%)

VRNS Varonis
$85.00 /

+1.89 (+2.27%)

Conference/Events
BTIG life science/diagnostics analyst to hold analyst/industry conference call » 11:25
05/28/20
05/28
11:25
05/28/20
11:25

Life Science &…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Hot Stocks
FDA announces Oct. 16, 2021 new effective date for final cigarette labeling rule » 11:24
05/28/20
05/28
11:24
05/28/20
11:24
BTI

British American Tobacco

$40.71 /

+0.25 (+0.62%)

, MO

Altria Group

$39.06 /

+0.005 (+0.01%)

, PM

Philip Morris

$74.02 /

+0.14 (+0.19%)

, IMBBY

Imperial Brands

$0.00 /

+ (+0.00%)

The FDA stated in a post…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BTI British American Tobacco
$40.71 /

+0.25 (+0.62%)

MO Altria Group
$39.06 /

+0.005 (+0.01%)

PM Philip Morris
$74.02 /

+0.14 (+0.19%)

IMBBY Imperial Brands
$0.00 /

+ (+0.00%)

BTI British American Tobacco
$40.71 /

+0.25 (+0.62%)

04/07/20 Morgan Stanley
Morgan Stanley upgrades 'safe haven' British American Tobacco to Overweight
04/07/20 Morgan Stanley
British American Tobacco upgraded to Overweight at Morgan Stanley
03/20/20 Jefferies
Altria suspension makes stock 'hard to own,' says Jefferies
03/05/20
Fly Intel: Top five analyst upgrades
MO Altria Group
$39.06 /

+0.005 (+0.01%)

04/20/20 Deutsche Bank
Altria Group price target lowered to $51 from $56 at Deutsche Bank
04/09/20 Piper Sandler
Piper Sandler a buyer of 'undervalued, defensive' Altria Group
04/03/20 Panmure Gordon
Altria Group upgraded to Buy from Hold at Panmure Gordon
04/01/20 Goldman Sachs
Altria Group resumed with a Neutral at Goldman Sachs
PM Philip Morris
$74.02 /

+0.14 (+0.19%)

04/03/20 Panmure Gordon
Philip Morris upgraded to Buy from Hold at Panmure Gordon
04/01/20 Goldman Sachs
Philip Morris resumed with a Buy at Goldman Sachs
03/23/20 Piper Sandler
Philip Morris recent share selloff looks overdone, says Piper Sandler
02/13/20
Fly Intel: Top five analyst upgrades
IMBBY Imperial Brands
$0.00 /

+ (+0.00%)

04/07/20 Morgan Stanley
Imperial Brands price target lowered to 1,656 GBp from 1,685 GBp at Morgan Stanley
03/31/20 Piper Sandler
Imperial Brands upgraded to Overweight from Neutral at Piper Sandler
03/30/20 Deutsche Bank
Imperial Brands price target lowered to 2,000 GBp at Deutsche Bank
03/20/20 Jefferies
Altria suspension makes stock 'hard to own,' says Jefferies
MO Altria Group
$39.06 /

+0.005 (+0.01%)

PM Philip Morris
$74.02 /

+0.14 (+0.19%)

BTI British American Tobacco
$40.71 /

+0.25 (+0.62%)

MO Altria Group
$39.06 /

+0.005 (+0.01%)

PM Philip Morris
$74.02 /

+0.14 (+0.19%)

IMBBY Imperial Brands
$0.00 /

+ (+0.00%)

BTI British American Tobacco
$40.71 /

+0.25 (+0.62%)

MO Altria Group
$39.06 /

+0.005 (+0.01%)

PM Philip Morris
$74.02 /

+0.14 (+0.19%)

IMBBY Imperial Brands
$0.00 /

+ (+0.00%)

MO Altria Group
$39.06 /

+0.005 (+0.01%)

PM Philip Morris
$74.02 /

+0.14 (+0.19%)

Recommendations
Bank of Montreal price target raised to C$75 from C$73 at Scotiabank » 11:23
05/28/20
05/28
11:23
05/28/20
11:23
BMO

Bank of Montreal

$50.29 /

-1.38 (-2.67%)

Scotiabank analyst Sumit…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BMO Bank of Montreal
$50.29 /

-1.38 (-2.67%)

BMO Bank of Montreal
$50.29 /

-1.38 (-2.67%)

10:48 Today RBC Capital
Bank of Montreal price target lowered to C$75 from C$76 at RBC Capital
10:42 Today Canaccord
Bank of Montreal price target raised to C$79 from C$73 at Canaccord
10:29 Today TD Securities
Bank of Montreal price target lowered to C$80 from C$85 at TD Securities
05/27/20 National Bank
Bank of Montreal downgraded to Sector Perform from Outperform at National Bank
BMO Bank of Montreal
$50.29 /

-1.38 (-2.67%)

BMO Bank of Montreal
$50.29 /

-1.38 (-2.67%)

Recommendations
Acadian Timber price target lowered to C$16.50 from C$17 at Scotiabank » 11:22
05/28/20
05/28
11:22
05/28/20
11:22
ACAZF

Acadian Timber

$0.00 /

+ (+0.00%)

Scotiabank analyst Benoit…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ACAZF Acadian Timber
$0.00 /

+ (+0.00%)

05/08/20 RBC Capital
Acadian Timber price target lowered to C$15 from C$16 at RBC Capital
05/07/20 Scotiabank
Acadian Timber price target lowered to C$17 from C$18 at Scotiabank
03/30/20 Credit Suisse
Acadian Timber downgraded to Neutral from Outperform at Credit Suisse
02/04/20 Credit Suisse
Mercer downgraded to Neutral ahead of earnings at Credit Suisse
Hot Stocks
Toll Brothers well positioned for challenges ahead  11:20
05/28/20
05/28
11:20
05/28/20
11:20
TOL

Toll Brothers

$33.13 /

+0.185 (+0.56%)

 
ShowHide Related Items >><<
TOL Toll Brothers
$33.13 /

+0.185 (+0.56%)

TOL Toll Brothers
$33.13 /

+0.185 (+0.56%)

05/27/20 Credit Suisse
Toll Brothers initiated with a Neutral at Credit Suisse
05/27/20 Credit Suisse
KB Home initiated with an Outperform at Credit Suisse
05/11/20 Wedbush
Toll Brothers price target lowered to $35 from $48 at Wedbush
05/04/20 Evercore ISI
Toll Brothers upgraded to In Line from Underperform at Evercore ISI
TOL Toll Brothers
$33.13 /

+0.185 (+0.56%)

TOL Toll Brothers
$33.13 /

+0.185 (+0.56%)

TOL Toll Brothers
$33.13 /

+0.185 (+0.56%)

Hot Stocks
Toll Brothers 'encouraged' by pick up in deposits in May  11:19
05/28/20
05/28
11:19
05/28/20
11:19
TOL

Toll Brothers

$33.03 /

+0.085 (+0.26%)

 
ShowHide Related Items >><<
TOL Toll Brothers
$33.03 /

+0.085 (+0.26%)

TOL Toll Brothers
$33.03 /

+0.085 (+0.26%)

05/27/20 Credit Suisse
Toll Brothers initiated with a Neutral at Credit Suisse
05/27/20 Credit Suisse
KB Home initiated with an Outperform at Credit Suisse
05/11/20 Wedbush
Toll Brothers price target lowered to $35 from $48 at Wedbush
05/04/20 Evercore ISI
Toll Brothers upgraded to In Line from Underperform at Evercore ISI
TOL Toll Brothers
$33.03 /

+0.085 (+0.26%)

TOL Toll Brothers
$33.03 /

+0.085 (+0.26%)

TOL Toll Brothers
$33.03 /

+0.085 (+0.26%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.